ctrl K

Watchlist Price Alert

Dermata Therapeutics Inc. (DRMA)

NASDAQ: DRMA · Real-Time Price · USD

0.71

0.01 (1.43%)

At close: Jun 17, 2025, 1:05 PM

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	322.00	1.35K
Gross Profit	n/a	n/a	n/a	n/a	-322	-1.35K
Operating Income	-12.51B	-8.04M	-9.67M	-7.86M	-3.17M	-4.47M
Interest Income	225.78K	247.22K	63.57K	45.61	197.27	n/a
Pretax Income	-12.29B	-7.79M	-9.61M	-7.9M	-3.24M	-4.72M
Net Income	-12.29B	-7.79M	-9.61M	-7.9M	-3.24M	-4.97M
Selling & General & Admin	4.31B	3.97M	4.02M	4.4M	1.56M	1.85M
Research & Development	8.2B	4.07M	5.65M	3.46M	1.61M	2.62M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.51M	8.04M	9.67M	7.86M	3.17M	4.47M
Interest Expense	n/a	n/a	n/a	45.61K	197.27K	250.75K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	8.04M	9.67M	7.86M	3.17M	4.47M
Income Tax Expense	n/a	n/a	-9.67K	45.61K	197.27K	250.75K
Shares Outstanding (Basic)	1.53M	194K	690.67K	520.54K	34.7K	34.7K
Shares Outstanding (Diluted)	1.53M	194.96K	690.67K	520.54K	34.7K	34.7K
EPS (Basic)	-8.03K	-40.18	-13.92	-15.27	-6.6	-9.55
EPS (Diluted)	-8.03K	-39.98	-13.92	-15.27	-6.6	-9.55
EBITDA	-12.29M	247.22K	-9.67M	-7.86M	-3.17M	-4.47M
EBIT	-12.29M	-7.79M	-9.61M	-7.86M	-3.17M	-4.47M
Depreciation & Amortization	12.51M	8.04M	9.67M	322.00	322.00	1.35K